Prognostic analysis of astrocytic gliomas correlating histological parameters with the proliferating cell nuclear antigen labelling index (PCNA-LI).
Eighty out of 250 cases of astrocytic glioma collected from a practice served by a single clinical team over a 15-year period were studied using a full complement of clinical, follow up, histopathological analysis and proliferating cell nuclear antigen (PCNA) immunostaining for the obtention of the PCNA-labelling index (LI). A statistical evaluation and discriminant analysis were carried out with the aim of clarifying the importance of various parameters as predictors of tumor behaviour. Data are correlated with survival (with a 10-year follow up). A significant correlation with survival was found when histological grouping and the PCNA-LI were studied with the Cox test. Most significant features were histological as detected using classical techniques including histological grading. The utilization of objective values (mitosis, cellular density and necrosis) appears to be useful in grading astrocytic tumors. Our results emphasize the importance of cytological, histological and PCNA-LI parameters as predictors of tumor behaviour.
Cruz-Sánchez
F F
FF
Neurological Tissue Bank, Hospital Clínico y Provincial, School of Medicine, University of Barcelona, Spain.
Ferreres
J C
JC
Figols
J
J
Palacin
A
A
Cardesa
A
A
Rossi
M L
ML
Val-Bernal
J F
JF
D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000276:immunology* / Q000401:mortality / Q000473:pathology*; D001932:Brain Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology*; D002455:Cell Division; D002648:Child; D002675:Child, Preschool; D005260:Female; D005909:Glioblastoma / Q000276:immunology / Q000401:mortality / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism*; D015996:Survival Rate
D018809:Proliferating Cell Nuclear Antigen